AVEN: a novel oncogenic biomarker with prognostic significance and implications of AVEN-associated immunophenotypes in lung adenocarcinoma

Overview of attention for article published in Frontiers in Molecular Biosciences, October 2023

Altmetric Badge

Mentioned by

twitter: 1 X user

Readers on

mendeley: 2 Mendeley

So far, Altmetric has seen 1 X post from an account with 2,499 followers.

New Research: AVEN: a novel oncogenic biomarker with prognostic significance and implications of AVEN-associated immunophenotypes in lung adenocarcinoma https://t.co/nvdpWiPnvD #MolBioSci

16 Oct 2023

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.